About Y-MABS THERAPEUTICS, INC
Y-mAbs Therapeutics, now part of SERB Pharmaceuticals, develops and commercializes novel radioimmunotherapy and antibody-based therapies for life-threatening diseases. The company focuses on innovative therapeutic solutions to improve and extend patients' lives.
Development and commercialization of radioimmunotherapyDevelopment of antibody-based therapiesTreatment of relapsed or refractory high-risk neuroblastomaPartnership opportunities in oncology treatments
Is this your company?
Claim Y-MABS THERAPEUTICS, INC to unlock the federal & state contracts GovIntel's AI has matched to you right now — plus your own scored past-performance, who you're up against, and who's risky to team with.
Claim Y-MABS THERAPEUTICS, INC & see your matchesFree to claim. Takes about a minute.
Data compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate, or want this page removed? Request a correction or removal.